Clinical trials recruiting in Leidschendam, Netherlands

Phase breakdown

Conditions recruiting in Leidschendam, Netherlands

Recruiting trials in Leidschendam, Netherlands

• A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
  NCT06692738 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
  NCT06793215 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
  NCT05512364 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Induction Chemotherapy for Locally Recurrent Rectal Cancer
  NCT04389086 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Minimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer
  NCT04486495 · Phase: Not specified · Ages: 18 Years and older · Sex: Female
• Towards Optimal Treatment for High Risk Prostate Cancer
  NCT06204341 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male

Common questions

How many clinical trials are recruiting in Leidschendam, Netherlands?

6 recruiting trials have at least one study site in Leidschendam, Netherlands.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.